Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-18

FDA Approved: LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA granted supplemental approval for a lansoprazole-amoxicillin-clarithromycin combination product by Rising Pharma Holdings, Inc. to eradicate Helicobacte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • Lansoprazole (Lansoprazole)
  • clarithromycin (clarithromycin)

Snippet

SUPPL AP for LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN (LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN)